Engineering the next generation of CAR T- cells: precision modifications, logic gates and universal strategies to overcome exhaustion and tumor resistance.

Saved in:
Bibliographic Details
Title: Engineering the next generation of CAR T- cells: precision modifications, logic gates and universal strategies to overcome exhaustion and tumor resistance.
Authors: Garcia-Robledo JE; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Centro de Investigación en Hematología y Oncología (CIHO), IDC Instituto de Cáncer Hemato Oncólogos, Cali, Colombia., Cabrera-Salcedo S; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia., Brandauer AM; Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA, United States.; Department of Pediatrics, Harvard Medical School, Boston, MA, United States.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, United States., Romano F; Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA, United States.; Department of Pediatrics, Harvard Medical School, Boston, MA, United States.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, United States., Rengifo-Martinez J; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Clinical Research Center, Rio Grande Urology, El Paso, TX, United States., Toro-Pedroza A; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia., Victoria JS; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia., Rios-Serna LJ; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Centro de Investigación en Reumatología, Autoinmunidad y Medicina Traslacional (CIRAT), Universidad Icesi, Cali, Colombia., Loukanov A; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Department of Chemistry and Materials Science, National Institute of Technology, Gunma College, Maebashi, Japan., Cardona AF; Department of Oncology, Centro de Tratamiento e Investigación Sobre Cáncer Luis Carlos Sarmiento Angulo (CTIC), Bogotá, Colombia., Genovese P; Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA, United States.; Department of Pediatrics, Harvard Medical School, Boston, MA, United States.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, United States., Baena JC; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Department of Hematology/Oncology, Fundación Valle del Lili, Cali, Colombia.
Source: Frontiers in oncology [Front Oncol] 2026 Jan 09; Vol. 15, pp. 1698442. Date of Electronic Publication: 2026 Jan 09 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41584599
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Engineering the next generation of CAR T- cells: precision modifications, logic gates and universal strategies to overcome exhaustion and tumor resistance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Garcia-Robledo+JE%22">Garcia-Robledo JE</searchLink>; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Centro de Investigación en Hematología y Oncología (CIHO), IDC Instituto de Cáncer Hemato Oncólogos, Cali, Colombia.<br /><searchLink fieldCode="AU" term="%22Cabrera-Salcedo+S%22">Cabrera-Salcedo S</searchLink>; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia.<br /><searchLink fieldCode="AU" term="%22Brandauer+AM%22">Brandauer AM</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA, United States.; Department of Pediatrics, Harvard Medical School, Boston, MA, United States.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Romano+F%22">Romano F</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA, United States.; Department of Pediatrics, Harvard Medical School, Boston, MA, United States.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Rengifo-Martinez+J%22">Rengifo-Martinez J</searchLink>; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Clinical Research Center, Rio Grande Urology, El Paso, TX, United States.<br /><searchLink fieldCode="AU" term="%22Toro-Pedroza+A%22">Toro-Pedroza A</searchLink>; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia.<br /><searchLink fieldCode="AU" term="%22Victoria+JS%22">Victoria JS</searchLink>; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Faculty of Health Sciences, Universidad Icesi, Cali, Colombia.<br /><searchLink fieldCode="AU" term="%22Rios-Serna+LJ%22">Rios-Serna LJ</searchLink>; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Centro de Investigación en Reumatología, Autoinmunidad y Medicina Traslacional (CIRAT), Universidad Icesi, Cali, Colombia.<br /><searchLink fieldCode="AU" term="%22Loukanov+A%22">Loukanov A</searchLink>; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Department of Chemistry and Materials Science, National Institute of Technology, Gunma College, Maebashi, Japan.<br /><searchLink fieldCode="AU" term="%22Cardona+AF%22">Cardona AF</searchLink>; Department of Oncology, Centro de Tratamiento e Investigación Sobre Cáncer Luis Carlos Sarmiento Angulo (CTIC), Bogotá, Colombia.<br /><searchLink fieldCode="AU" term="%22Genovese+P%22">Genovese P</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA, United States.; Department of Pediatrics, Harvard Medical School, Boston, MA, United States.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, United States.<br /><searchLink fieldCode="AU" term="%22Baena+JC%22">Baena JC</searchLink>; LiliCAR-T Group, Fundación Valle del Lili, Cali, Colombia.; Department of Hematology/Oncology, Fundación Valle del Lili, Cali, Colombia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Jan 09; Vol. 15, pp. 1698442. <i>Date of Electronic Publication: </i>2026 Jan 09 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41584599
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1698442
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1698442
    Titles:
      – TitleFull: Engineering the next generation of CAR T- cells: precision modifications, logic gates and universal strategies to overcome exhaustion and tumor resistance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Garcia-Robledo JE
      – PersonEntity:
          Name:
            NameFull: Cabrera-Salcedo S
      – PersonEntity:
          Name:
            NameFull: Brandauer AM
      – PersonEntity:
          Name:
            NameFull: Romano F
      – PersonEntity:
          Name:
            NameFull: Rengifo-Martinez J
      – PersonEntity:
          Name:
            NameFull: Toro-Pedroza A
      – PersonEntity:
          Name:
            NameFull: Victoria JS
      – PersonEntity:
          Name:
            NameFull: Rios-Serna LJ
      – PersonEntity:
          Name:
            NameFull: Loukanov A
      – PersonEntity:
          Name:
            NameFull: Cardona AF
      – PersonEntity:
          Name:
            NameFull: Genovese P
      – PersonEntity:
          Name:
            NameFull: Baena JC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 01
              Text: 2026 Jan 09
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1